4.7 Article

Protection of Two and Three mRNA Vaccine Doses Against Severe Outcomes Among Adults Hospitalized With COVID-19-VISION Network, August 2021 to March 2022

Related references

Note: Only part of the references are listed.
Article Public, Environmental & Occupational Health

Estimates of COVID-19 vaccine uptake in major occupational groups and detailed occupational categories in the United States, April-May 2021

Paul K. Henneberger et al.

Summary: This study examines the COVID-19 vaccine uptake among different occupational groups in the United States. The findings show varying vaccination rates among different professions, with some occupations having significantly lower percentages of vaccinated individuals. These results are important for informing future vaccination promotion activities targeted at specific occupations during viral epidemics and pandemics.

AMERICAN JOURNAL OF INDUSTRIAL MEDICINE (2022)

Review Infectious Diseases

SARS-CoV-2 vaccine effectiveness against infection, symptomatic and severe COVID-19: a systematic review and meta-analysis

Paddy Ssentongo et al.

Summary: This study retrospectively reviewed and analyzed the duration of SARS-CoV-2 vaccine efficacy against infection, symptomatic COVID-19, and severe COVID-19. The results showed that the protection against SARS-CoV-2 infection and symptomatic COVID-19 decreased over time, while the protection against severe COVID-19 remained high.

BMC INFECTIOUS DISEASES (2022)

Article Immunology

Effects of Confounding Bias in Coronavirus Disease 2019 (COVID-19) and Influenza Vaccine Effectiveness Test-Negative Designs Due to Correlated Influenza and COVID-19 Vaccination Behaviors

Margaret K. Doll et al.

Summary: Vaccine effectiveness estimates for influenza and COVID-19 may be biased due to correlated vaccination behaviors, and it is important to address this bias in test-negative studies.

CLINICAL INFECTIOUS DISEASES (2022)

Article Infectious Diseases

Length of hospital stay and risk of intensive care admission and in-hospital death among COVID-19 patients in Norway: a register-based cohort study comparing patients fully vaccinated with an mRNA vaccine to unvaccinated patients

Robert Whittaker et al.

Summary: In Norway, fully vaccinated COVID-19 patients have shorter hospital stays, lower risk of ICU admission, and no difference in ICU stay or risk of in-hospital death compared to unvaccinated patients.

CLINICAL MICROBIOLOGY AND INFECTION (2022)

Article Medicine, General & Internal

Adults hospitalized with breakthrough COVID-19 have lower mortality than matched unvaccinated adults

Laura C. Myers et al.

Summary: The in-hospital mortality rate of COVID-19 patients is lower among those who are fully vaccinated compared to those who are unvaccinated, according to a retrospective cohort study.

JOURNAL OF INTERNAL MEDICINE (2022)

Editorial Material Medicine, General & Internal

Efficiency decreases

Halane Vaillant-Roussel et al.

EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE (2022)

Article Medicine, General & Internal

Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study

Adam S. Lauring et al.

Summary: mRNA vaccines were highly effective in preventing covid-19 associated hospital admissions related to the alpha, delta, and omicron variants. Three vaccine doses were required for protection against omicron, while two doses provided protection against delta and alpha variants. Omicron variant showed lower disease severity compared to delta variant but still resulted in morbidity and mortality. Vaccinated patients had lower disease severity than unvaccinated patients for all the variants.

BMJ-BRITISH MEDICAL JOURNAL (2022)

Article Public, Environmental & Occupational Health

Effectiveness of mRNA Vaccination in Preventing COVID-19–Associated Invasive Mechanical Ventilation and Death — United States, March 2021–January 2022

Mark W. Tenforde et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2022)

Article Public, Environmental & Occupational Health

COVID-19 Vaccination Coverage, by Race and Ethnicity — National Immunization Survey Adult COVID Module, United States, December 2020–November 2021

Jennifer L. Kriss et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2022)

Review Medicine, General & Internal

Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression

Daniel R. Feikin et al.

Summary: This study systematically reviewed the duration of protection provided by COVID-19 vaccines against various clinical outcomes. The findings indicate that the effectiveness or efficacy of the vaccines decreased from 1 to 6 months after full vaccination, but remained high against severe disease. Evaluating the effectiveness or efficacy of vaccines beyond 6 months is crucial for updating vaccine policies.

LANCET (2022)

Article Public, Environmental & Occupational Health

Unique Predictors of Intended Uptake of a COVID-19 Vaccine in Adults Living in a Rural College Town in the United States

Robert P. Lennon et al.

Summary: A study conducted in a rural college town in central Pennsylvania found that a lower proportion of adult residents who had taken the flu vaccine were willing to take a COVID-19 vaccine. Trust in the system evaluating vaccines and perceptions of local COVID-19 vaccination norms were found to be the strongest predictors of vaccine acceptance, while worries about unknown side-effects and positive attitudes toward natural infection were the strongest predictors of negative vaccine intentions. Traditional sociodemographic factors, political views, and religiosity did not predict vaccine intentions.

AMERICAN JOURNAL OF HEALTH PROMOTION (2022)

Article Public, Environmental & Occupational Health

Major disparities in COVID-19 test positivity for patients with non-English preferred language even after accounting for race and social factors in the United States in 2020

Hannah Cohen-Cline et al.

Summary: The study revealed that individuals whose preferred language is not English are at a higher risk of testing positive for COVID-19, even after adjusting for age, race/ethnicity, and social factors. This highlights a significant inequity in healthcare access and outcomes for non-English speakers.

BMC PUBLIC HEALTH (2021)

Article Medicine, General & Internal

Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity

Mark W. Tenforde et al.

Summary: This study evaluated the association between mRNA COVID-19 vaccines and COVID-19 hospitalization, as well as disease progression to critical illness among hospitalized patients. The results showed that vaccination with mRNA COVID-19 vaccines significantly decreased the likelihood of COVID-19 hospitalization and disease progression to death or mechanical ventilation.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Article Public, Environmental & Occupational Health

Individual and social determinants of COVID-19 vaccine uptake

K. Viswanath et al.

Summary: Our study identified race/ethnicity, risk perceptions, exposure to different media for COVID-19 news, party identification and confidence in scientists as factors that would be affecting COVID-19 vaccine uptake. The good news is that these are addressable through strategic public health communications, but a lot of work remains to be done with some urgency.

BMC PUBLIC HEALTH (2021)

Article Medicine, General & Internal

Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings

M. G. Thompson et al.

Summary: A study with a test-negative design analyzed 41,552 admissions to 187 hospitals and 21,522 visits to 221 EDs or urgent care clinics. The mRNA-based vaccines (>= 14 days after the second dose) were highly effective against SARS-CoV-2 infection leading to hospitalization (89%), ICU admission (90%), or an urgent care visit (91%).

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Medicine, General & Internal

Attitudes Toward a Potential SARS-CoV-2 Vaccine A Survey of US Adults

Kimberly A. Fisher et al.

ANNALS OF INTERNAL MEDICINE (2020)

Article Medicine, General & Internal

Determinants of COVID-19 vaccine acceptance in the US

Amyn A. Malik et al.

ECLINICALMEDICINE (2020)

Article Medicine, General & Internal

Effectiveness of the influenza vaccine in preventing admission to hospital and death in people with type 2 diabetes

Eszter P. Vamos et al.

CANADIAN MEDICAL ASSOCIATION JOURNAL (2016)

Article Public, Environmental & Occupational Health

Negative Controls A Tool for Detecting Confounding and Bias in Observational Studies

Marc Lipsitch et al.

EPIDEMIOLOGY (2010)

Article Respiratory System

Impact of influenza vaccination on mortality risk among the elderly

R. H. H. Groenwold et al.

EUROPEAN RESPIRATORY JOURNAL (2009)